4.7 Article

The US food and drug administration perspective on cancer biomarker development

Journal

NATURE REVIEWS CANCER
Volume 6, Issue 7, Pages 565-571

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrc1911

Keywords

-

Categories

Ask authors/readers for more resources

Despite the intense interest in biomarker development for cancer management, few biomarker assays for diagnostic uses have been submitted to the US Food and Drug Administration (FDA). What challenges must researchers overcome to bring cancer-detection technologies to the market and, therefore, into clinical use?

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available